Skip to main content
Pulmonary Medicine logoLink to Pulmonary Medicine
. 2020 Jul 30;2020:7291698. doi: 10.1155/2020/7291698

Epidemiology of COVID-19 and Predictors of Recovery in the Republic of Korea

Ashis Kumar Das 1,, Saji Saraswathy Gopalan 2
PMCID: PMC7395990  PMID: 32774918

Abstract

Background

The recent COVID-19 pandemic has emerged as a threat to global health. Though current evidence on the epidemiology of the disease is emerging, very little is known about the predictors of recovery.

Objectives

To describe the epidemiology of confirmed COVID-19 patients in the Republic of Korea and identify predictors of recovery.

Materials and Methods

Using publicly available data for confirmed COVID-19 cases from the Korea Centers for Disease Control and Prevention from January 20, 2020, to April 30, 2020, we undertook descriptive analyses of cases stratified by sex, age group, place of exposure, date of confirmation, and province. Correlation was tested among all predictors (sex, age group, place of exposure, and province) with Pearson's correlation coefficient. Associations between recovery from COVID-19 and predictors were estimated using a multivariable logistic regression model.

Results

Majority of the confirmed cases were females (56%), 20-29 age group (24.3%), and primarily from three provinces—Gyeongsangbuk-do (36.9%), Gyeonggi-do (20.5%), and Seoul (17.1%). The case fatality ratio was 2.1%, and 41.6% cases recovered. Older patients, patients from provinces such as Daegu, Gyeonggi-do, Gyeongsangbuk-do, Jeju-do, Jeollabuk-do, and Jeollanam-do, and those contracting the disease from healthcare settings had lower recovery.

Conclusions

Our study adds to the very limited evidence base on potential predictors of recovery among confirmed COVID-19 cases. We call additional research to explore the predictors of recovery and support development of policies to protect the vulnerable patient groups.

1. Introduction

For the first time, a novel coronavirus disease 2019 (COVID-19) originating from Wuhan in China was reported to the World Health Organization in December of 2019 [1]. This novel coronavirus has taken the form of a major pandemic and has affected almost all major nations in the world. There have been more than 3.6 million confirmed cases and about 252,000 deaths as of May 05, 2020 [2]. The very first COVID-19 case was diagnosed in the Republic of Korea (South Korea) on January 20, 2020 [3]. During the first two months of this global epidemic, South Korea had the second highest cases globally following China. According to the Korea Centers for Disease Control and Prevention (KCDC), there have been 10,804 confirmed cases and 254 deaths due to COVID-19 as of May 05, 2020 [4].

We present the epidemiology of COVID-19 in the Republic of Korea using data from the Korea Centers for Disease Control and Prevention and identify the predictors of recovery from the disease.

2. Materials and Methods

2.1. Data Source

The data were obtained from the Korea Centers for Disease Control and Prevention's publicly shared sources. The dataset contains information about 3,388 confirmed COVID-19 cases in the Republic of Korea from January 20, 2020, through April 30, 2020. After excluding cases with missing values, 3,299 cases were included in the analysis.

2.2. Variables

A confirmed case was defined as a person with laboratory-confirmed positive test. The data contained the following patient details: age (in groups), sex, province, date of diagnosis, mode of exposure, and outcome. There were 11 age groups: below10 years, 10-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, 80-89 years, 90-99 years, and above 100 years. We combined the last two age groups to create 90 years and above and thus recategorized age to 10 groups. All seventeen provinces of the Republic of Korea were represented: Busan, Chungcheongbuk-do, Chungcheongnam-do, Daegu, Daejeon, Gangwon-do, Gwangju, Gyeonggi-do, Gyeongsangbuk-do, Gyeongsangnam-do, Incheon, Jeju-do, Jeollabuk-do, Jeollanam-do, Sejong, Seoul, and Ulsan. We categorized the dates of diagnosis by weeks, and they were as follows: 20-26 Jan 2020, 27 Jan-02 Feb 2020, 03-09 Feb 2020, 10-16 Feb 2020, 17-23 Feb 2020, 24 Feb-01 Mar 2020, 02-08 Mar 2020, 09-15 Mar 2020, 16-22 Mar 2020, 23-29 Mar 2020, 30 Mar-05 Apr 2020, 06-12 Apr 2020, 13-19 Apr 2020, 20-26 Apr 2020, and 27-30 Apr 2020. Patients were exposed to potential COVID-19 sources in multiple settings. The settings were nursing home, hospital, religious gathering, call center, community center, shelter and apartment, gym facility, overseas inflow, contact with patients, and others. There were three outcomes: death, recovery, and isolation. The confirmed patients after spending some days in isolation were retested. They were considered recovered only after receiving a negative COVID-19 test.

2.3. Statistical Methods

We undertook descriptive analyses for the patient characteristics and presented the results stratified by subgroups for each characteristic. Correlation was tested among all patient characteristics with Pearson's correlation coefficient. Associations between recovery from COVID-19 and predictors (age group, sex, province, and exposure) were estimated using a multivariable logistic regression model. We considered associations statistically significant if the p value was below 0.05. The statistical analyses were performed using Python programming language Version 3.7 (Python Software Foundation, Wilmington, DE, USA) and Stata Version 15 (StataCorp LLC, College Station, TX).

3. Results

3.1. Pattern of the Epidemic

As shown in Figure 1, the first case of COVID-19 was confirmed on January 20, 2020. There were a few daily cases of new infections for about a month. After a month, the curve suddenly rose starting February 19, 2020, to reach the peak around end of February and early March. It reached its peak on the 29th of February with 813 confirmed cases. Though the curve descended after this date, still there were on an average 200 daily new confirmed cases until March 11, 2020. The curve continued its downward trend, however, adding at least 100 new daily cases through April 05, 2020. Towards the end of April, daily new confirmed cases were below 10.

Figure 1.

Figure 1

Daily new confirmed COVID-19 cases in the Republic of Korea between January 20, 2020, and April 30, 2020.

3.2. Patient Profile

Table 1 shows the profile of the patients. Out of 3,299 confirmed patients, slightly more than half were females (56%). While there were cases from all age groups, the maximum patients were 20-29 years (24.3%), followed by 50-59 years (18.1%), 40-49 years (13.8%), 30-39 years (13.3%), and 60-69 years (12.2%). Three provinces—Gyeongsangbuk-do (36.9%), Gyeonggi-do (20.5%), and Seoul (17.1%)—together accounted for the maximum patients. With respect to the exposure, it was unknown for the most (44%) followed by direct contact with patients (29%), from overseas (16.8%), and religious gathering (4.9%). According to this available data source, 85% percent of the patients were confirmed of their diagnosis between 24 February and 05 April of 2020. There were 61 deaths accounting for 2.1 percent (case fatality rate) of the patients. More than half were isolated (56.3%), and 41.6% recovered.

Table 1.

Sample characteristics (N = 3,299).

Variable Number Proportion (%)
Sex
 Female 1,848 56.0
 Male 1,451 44.0
Age group (years)
 Below 10 53 1.6
 10-19 149 4.5
 20-29 801 24.3
 30-39 438 13.3
 40-49 454 13.8
 50-59 597 18.1
 60-69 401 12.2
 70-79 204 6.2
 80-89 156 4.7
 90 and above 46 1.4
Province
 Busan 134 4.1
 Chungcheongbuk-do 44 1.3
 Chungcheongnam-do 143 4.3
 Daegu 63 1.9
 Daejeon 40 1.2
 Gangwon-do 49 1.5
 Gwangju 30 0.9
 Gyeonggi-do 677 20.5
 Gyeongsangbuk-do 1,218 36.9
 Gyeongsangnam-do 112 3.4
 Incheon 92 2.8
 Jeju-do 13 0.4
 Jeollabuk-do 17 0.5
 Jeollanam-do 15 0.5
 Sejong 46 1.4
 Seoul 563 17.1
 Ulsan 43 1.3
Exposure
 Nursing home 46 1.4
 Hospital 37 1.1
 Religious gathering 160 4.9
 Call center 112 3.4
 Community center, shelter, and apartment 50 1.5
 Gym facility 34 1.0
 Overseas inflow 553 16.8
 Contact with patients 957 29.0
 Others 1,350 40.9
Date of confirmed diagnosis
 20-26 Jan 2020 3 0.1
 27 Jan-02 Feb 2020 12 0.4
 03-09 Feb 2020 12 0.4
 10-16 Feb 2020 3 0.1
 17-23 Feb 2020 258 7.8
 24 Feb-01 Mar 2020 750 22.7
 02-08 Mar 2020 651 19.7
 09-15 Mar 2020 356 10.8
 16-22 Mar 2020 348 10.6
 23-29 Mar 2020 347 10.5
 30 Mar-05 Apr 2020 349 10.6
 06-12 Apr 2020 102 3.1
 13-19 Apr 2020 71 2.2
 20-26 Apr 2020 30 0.9
 27-30 Apr 2020 7 0.2
Outcome
 Died 69 2.1
 Recovered 1,372 41.6
 Isolated 1,858 56.3

3.3. Predictors of Recovery

As shown in Figure 2, there were no correlations between the predictors. Both males and females had similar recovery rates, and their difference was not statistically significant (Table 2). Compared to younger age groups, older patients had lower recovery: 70-79 years (adjusted odds ratio 0.31; p value 0.01), 80-89 years (aOR 0.22; p value 0.001), and 90 years and above (aOR 0.13; p value < 0.001). Provinces such as Daegu, Gyeonggi-do, Gyeongsangbuk-do, Jeju-do, Jeollabuk-do, and Jeollanam-do had statistically significant lower recovery rates than Busan. When compared with exposure from nursing homes, patients who were exposed to COVID-19 infection from religious gatherings, community dwellings, and others had higher recovery rates.

Figure 2.

Figure 2

Correlation among predictors. Cells show Pearson's correlation coefficient.

Table 2.

Predictors of recovery.

Variable Recovery (%) Odds ratio 95% confidence interval p value
Sex
 Female 56.6 Reference
 Male 56.0 0.90 0.73-1.10 0.312
Age group (years)
 Below 10 60.4 Reference
 10-19 58.4 1.33 0.55-3.25 0.527
 20-29 46.8 1.51 0.68-3.36 0.314
 30-39 50.7 1.77 0.78-4.04 0.173
 40-49 38.8 1.13 0.50-2.56 0.771
 50-59 39.5 1.02 0.45-2.31 0.955
 60-69 44.4 0.81 0.35-1.84 0.611
 70-79 38.7 0.31 0.13-0.76 0.01
 80-89 32.7 0.22 0.09-0.54 0.001
 90 and above 32.6 0.13 0.04-0.37 <0.001
Province
 Busan 82.8 Reference
 Chungcheongbuk-do 88.6 1.02 0.35-2.99 0.971
 Chungcheongnam-do 88.8 1.38 0.61-3.12 0.432
 Daegu 6.4 0.00 0.00-0.01 <0.001
 Daejeon 85.0 1.38 0.43-4.44 0.585
 Gangwon-do 59.2 0.30 0.12-0.78 0.013
 Gwangju 70.0 0.67 0.25-1.79 0.424
 Gyeonggi-do 9.0 0.01 0.01-0.02 <0.001
 Gyeongsangbuk-do 63.5 0.10 0.05-0.19 <0.001
 Gyeongsangnam-do 85.7 0.93 0.40-2.15 0.866
 Incheon 59.8 0.55 0.26-1.18 0.125
 Jeju-do 53.9 0.29 0.08-1.00 0.05
 Jeollabuk-do 23.5 0.03 0.01-0.11 <0.001
 Jeollanam-do 20.0 0.03 0.01-0.13 <0.001
 Sejong 87.0 1.20 0.25-5.86 0.821
 Seoul 74.1 0.70 0.38-1.29 0.257
 Ulsan 86.1 1.24 0.32-4.83 0.76
Exposure
 Nursing home 17.4 Reference
 Hospital 43.2 1.14 0.34-3.85 0.833
 Religious gathering 80.6 6.29 1.80-21.94 0.004
 Call center 84.8 2.68 0.77-9.31 0.122
 Community center, shelter, and apartment 82.0 13.34 3.06-58.05 0.001
 Gym facility 94.1 6.05 0.63-57.79 0.118
 Overseas inflow 40.9 2.71 0.90-8.13 0.075
 Contact with patients 41.5 2.80 0.98-8.03 0.055
 Others 67.7 7.14 2.58-19.75 <0.001

4. Discussion

Due to multipronged approaches (proactive surveillance, higher testing, isolation, quarantine, use of technology, masks, and social distancing campaigns) by the government, incidence of new cases came down sharply in South Korea by mid-March and further to less than 10 new cases by mid-April [5].

Our study shows that females constituted the majority of confirmed cases, whereas males accounted for most of the confirmed cases in China and Italy [69]. Around a fourth of the cases were from the 20-29 years age group unlike in most other countries where the infected were older [6, 7, 10]. As already pointed out by researchers from South Korea, the possible reason for higher representation of younger population in our sample could also be specific exposure to cluster of cases through participation in religious activities or workplaces [5, 11]. As shown in a study undertaken in Europe, population density might have played a role for the number of higher cases in certain provinces [12]. The case fatality rate was much lower (2.1%) compared to other countries such as Italy (13.3%) and China (4%). Similar to findings from several other countries, we found the elderly to be more vulnerable with lower probabilities of recovery [6, 8, 13]. It is quite possible that the presence of preexisting medical conditions in the elderly predispose them to delayed recovery. We also found that cases contracting the infection in nonhealthcare setting had higher recovery. While there is no such evidence currently, there could be a possibility that the exposure outside nonhealthcare setting might have involved relatively younger and healthier cases. Considering our study findings, we suggest additional measures to protect the vulnerable cases who are less likely to recover from the infection. Thus, the elderly and cases contracting infection from healthcare settings should be given special attention.

Our study has two potential limitations. First, we used publicly available data of only a third of confirmed cases in the country. Thus, we are unable to ascertain the representativeness of the data for all confirmed cases in South Korea. So, the findings will have to be interpreted with caution. Second, the data lacks information of patients' symptoms and clinical features. Inclusion of these potential predictors would have enhanced the relevance of this study further. Despite these limitations, our study adds to the very limited evidence base on potential predictors of recovery among confirmed COVID-19 cases [14]. However, we believe the evidence base can be strengthened with further relevant research as authorities make more data publicly available or through primary hospital-based studies.

5. Conclusions

The COVID-19 pandemic has emerged as a great threat to global health challenging health systems across the world to efficiently deal with this situation. Emerging evidence on vulnerability to COVID-19 and predictors of recovery will inform providers and policy makers to effectively triage and prioritize limited resources. Therefore, we call for additional research to explore the predictors of recovery and support development of policies to protect the vulnerable patient groups.

Acknowledgments

We are grateful to Korea Centers for Disease Control and Prevention for making this data publicly available.

Data Availability

The data used to support the findings of this study are available publicly through the Korea Centers for Disease Control and Prevention.

Disclosure

The views expressed in the paper are that of the authors and do not reflect that of their affiliations.

Conflicts of Interest

The authors declare that there is no conflict of interest. This particular work was conducted outside of the authors' organizational affiliations.

References

  • 1.WHO. WHO coronavirus disease (COVID-2019) situation reports. World Health Organization; 2020. [Google Scholar]
  • 2.COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.
  • 3.Ryu S., Chun B. C. An interim review of the epidemiological characteristics of 2019 novel coronavirus. Epidemiol. Health. 2020;42 doi: 10.4178/epih.e2020006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.KCDC. Korea Centers for Disease Control and Prevention. Seoul, Korea: 2020. https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030. [Google Scholar]
  • 5.COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention. Coronavirus disease-19: the first 7, 755 cases in the Republic of Korea. Osong Public Health and Research Perspectives. 2020;11(2):85–90. doi: 10.24171/j.phrp.2020.11.2.05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Livingston E., Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA. 2020;323(14):p. 1335. doi: 10.1001/jama.2020.4344. [DOI] [PubMed] [Google Scholar]
  • 7.Guan W., Ni Z. Y., Hu Y., et al. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020;382(18):1708–1720. doi: 10.1056/nejmoa2002032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Li Q., Guan X., Wu P., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine. 2020;382(13):1199–1207. doi: 10.1056/NEJMoa2001316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chen N., Zhou M., Dong X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Sotgiu G., Gerli A. G., Centanni S., et al. Advanced forecasting of SARS-CoV-2-related deaths in Italy, Germany, Spain, and New York State. Allergy: European Journal of Allergy and Clinical Immunology. 2020;75(7):1813–1815. doi: 10.1111/all.14327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Park S. Y., Kim Y. M., Yi S., et al. Coronavirus disease outbreak in call center, South Korea. Emerging Infectious Diseases. 2020;26(8):1666–1670. doi: 10.3201/eid2608.201274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gerli A. G., Centanni S., Miozzo M. R., et al. COVID-19 mortality rates in the European Union, Switzerland, and the UK: effect of timeliness, lockdown rigidity, and population density. Minerva Medica. 2020 doi: 10.23736/S0026-4806.20.06702-6. [DOI] [PubMed] [Google Scholar]
  • 13.Nikpouraghdam M., Jalali Farahani A., Alishiri G. H., et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: a single center study. Journal of Clinical Virology. 2020;127:p. 104378. doi: 10.1016/j.jcv.2020.104378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Al-Rousan N., Al-Najjar H. Data analysis of coronavirus CoVID-19 epidemic in South Korea based on recovered and death cases. Journal of Medical Virology. 2020;10 doi: 10.1002/jmv.25850. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data used to support the findings of this study are available publicly through the Korea Centers for Disease Control and Prevention.


Articles from Pulmonary Medicine are provided here courtesy of Wiley

RESOURCES